ID
27695
Description
Study part: Vital Signs and ECOG Screening Day -7 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.
Keywords
Versions (1)
- 11/26/17 11/26/17 -
Copyright Holder
Charité – University of medicine Berlin
Uploaded on
November 26, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Vital Signs and ECOG Screening Day -7 to 0 SirTac NCT02936388
Vital Signs and ECOG Screening Day -7 to 0
- StudyEvent: ODM
Description
Befragung zur Lebensqualität nach EORTC QLQ-C30 Version 3 und EORTC QLQ-LMC21
Alias
- UMLS CUI-1
- C0034380
Description
EORTC QLQ-30
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0451149
- UMLS CUI [1,2]
- C4055104
Description
EORTC QLQ-LMC21
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0451149
- UMLS CUI [1,2]
- C4055104
Description
Date
Data type
date
Alias
- UMLS CUI [1]
- C0011008
Description
investigator name
Data type
text
Alias
- UMLS CUI [1]
- C2826892
Description
investigator signature
Data type
text
Alias
- UMLS CUI [1]
- C2346576
Similar models
Vital Signs and ECOG Screening Day -7 to 0
- StudyEvent: ODM
C0011008 (UMLS CUI [1,2])
C4055104 (UMLS CUI [1,2])
C4055104 (UMLS CUI [1,2])
No comments